Bartosz Chmielowski, MD, PhD

Bartosz Chmielowski, MD, PhD is a Health Sciences Clinical Professor of Medicine in the Division of Hematology-Oncology at the University of California Los Angeles. He is originally Polish and he graduated from the Medical School at Wroclaw, Poland. He moved to the United States to pursue research career in immunology at the Medical College of Georgia in Augusta, GA. He concentrated on studying T cell development in the thymus, especially the processes of positive and negative selection. His research resulted in a PhD thesis. He completed his residency in Internal Medicine at the Medical College of Georgia in Augusta, GA, and next, did his fellowship in Hematology-Oncology at UCLA. He has been ABIM certified in Medical Oncology and Hematology since 2008. Dr. Chmielowski has been a UCLA faculty member since 2008, and his both clinical and laboratory research concentrates on the development of new therapies for patients with melanoma, uveal melanoma, non-melanoma skin cancers and sarcoma. He has a special interest in the development of new immunotherapeutic agents and new combination immunotherapies not only in melanoma, but also in non-melanoma skin cancers and sarcoma including patients with gastrointestinal stromal tumors. In addition, he studies new molecularly targeted agents in both sarcoma and melanoma.

Patient Stories

Immunotherapy Is Making a Huge Difference!(Link is external) (Link opens in new window)